Literature DB >> 15317452

Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor.

Dan T Major1, Bilha Fischer.   

Abstract

P2Y receptors (P2Y-Rs) are attractive pharmaceutical targets due to their involvement in the modulation of many tissues and organs. The lack of experimental structural data on P2Y-Rs impedes structure-based drug design. The need to elucidate the receptor's molecular recognition, together with the limitations of previous receptor models, triggered the construction of a new molecular model for the h-P2Y1-R. Therefore, a h-P2Y1-R model was constructed by homology modeling using the 2.6 A crystal structure of bovine rhodopsin as a template and subsequently refined by constrained molecular dynamics (MD) simulations in a fully hydrated lipid bilayer environment. ATP was docked into the receptor binding site, followed by binding site refinement using Monte Carlo and MD simulations. Analysis of the h-P2Y1-R-ATP complex suggests that the triphosphate moiety is tightly bound by a multitude of interactions possibly including a Mg2+ ion, the ribose ring is not involved in specific interactions, and the adenine ring is bound via N1, N7, and N6. The molecular recognition of the h-P2Y1-R was further probed by ATP derivatives modified on the adenine ring, and correlated with EC50 values for these derivatives. Analysis of receptor:ligand complexes and quantum mechanical studies on model compounds support the role of both steric and electronic effects in improving H-bonding (via N1 and N6) and pi-stacking interactions. The computed h-P2Y1-R model was validated with respect to our previous biochemical results. We believe that this new model of the h-P2Y1-R provides the means for understanding phenomena such as the ligand's potency and receptor subtype selectivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317452     DOI: 10.1021/jm049772m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

2.  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

Authors:  Shay Eliahu; Alba Martín-Gil; María Jesús Perez de Lara; Jesús Pintor; Jean Camden; Gary A Weisman; Joanna Lecka; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

3.  Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor.

Authors:  Hyojin Ko; Ingrid Fricks; Andrei A Ivanov; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-04-04       Impact factor: 7.446

4.  Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.

Authors:  Guo Li; Philip D Mosier; Xianjun Fang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2009-04-19       Impact factor: 2.518

5.  Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Authors:  Yael Nadel; Joanna Lecka; Yocheved Gilad; Gal Ben-David; Daniel Förster; Georg Reiser; Sarah Kenigsberg; Jean Camden; Gary A Weisman; Hanoch Senderowitz; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2014-05-30       Impact factor: 7.446

6.  Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.

Authors:  Andrei A Ivanov; Stefano Costanzi; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2006-10-03       Impact factor: 3.686

7.  Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.

Authors:  D Ecke; M E Tulapurkar; V Nahum; B Fischer; G Reiser
Journal:  Br J Pharmacol       Date:  2006-09-04       Impact factor: 8.739

8.  Identification of hydrolytically stable and selective P2Y(1) receptor agonists.

Authors:  Shay E Eliahu; Jean Camden; Joanna Lecka; Gary A Weisman; Jean Sévigny; Sylvie Gélinas; Bilha Fischer
Journal:  Eur J Med Chem       Date:  2008-07-22       Impact factor: 6.514

9.  Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.

Authors:  Kenneth A Jacobson; M P Suresh Jayasekara; Stefano Costanzi
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-09-12

10.  A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Authors:  Tali Fishman Jacob; Vijay Singh; Mudit Dixit; Tamar Ginsburg-Shmuel; Begoña Fonseca; Jesus Pintor; Moussa B H Youdim; Dan T Major; Orly Weinreb; Bilha Fischer
Journal:  Purinergic Signal       Date:  2018-07-17       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.